Phase II Weekly Vinblastine for Chemotherapy-Naïve Children With Progressive Low-Grade Glioma: A Canadian Pediatric Brain Tumor Consortium Study
Álvaro Lassaletta(Hospital for Sick Children), Éric Bouffet(Hospital for Sick Children), Ute Bartels(Hospital for Sick Children), Katrin Scheinemann(University of Lucerne), Matthew Mistry(University of Toronto), Anthony Arnoldo(Hospital for Sick Children), Rahul Krishnatry, Vijay Ramaswamy(Hospital for Sick Children), Gregory R. Pond(Juravinski Hospital), Lucie Lafay‐Cousin(Women & Children's Hospital of Buffalo), Beverley Wilson, Ken Poskitt, Shayna Zelcer(London Health Sciences Centre), Annie Huang(Hospital for Sick Children), Donna L. Johnston(Children's Hospital of Eastern Ontario), David D. Eisenstat(Royal Children's Hospital), Cynthia Hawkins(Hospital for Sick Children), Nada Jabado(McGill University), Daniel Keene, Valérie Larouche, Uri Tabori(Universität Hamburg), Anne Sophie Carret(St Nicholas Hospital), Juliette Hukin(BC Children's Hospital)
Cited by 243
Related Papers
Medulloblastoma Comprises Four Distinct Molecular Variants
|Journal of Clinical Oncology|2010|1.4k
The whole-genome landscape of medulloblastoma subtypes
|Nature|2017|1.2k
K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomas
|Acta Neuropathologica|2012|1k
Immune Checkpoint Inhibition for Hypermutant Glioblastoma Multiforme Resulting From Germline Biallelic Mismatch Repair Deficiency
|Journal of Clinical Oncology|2016|867